Patents by Inventor Kazumi Araki

Kazumi Araki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4783403
    Abstract: L-phenylalanine is produced by using a microorganism belonging to the species Citrobacter freundii, Erwinia herbicola, Enterobacter cloacae, Klebsiella oxytoca, Salmonella typhimurium, Bacillus cereus, Flavobacterium suaveolens, Serratia marcescens, Pseudomonas putida, Enterobacter cloacae, Proteus mirabilis, Paracoccus denitrificans, Arthrobacter globiformis, Bacillus sphaericus, Corynebacterium hydrocarboclastus, Kluyvera micum or Microbacterium ammoniaphilum and having the ability to convert phenylpyruvic acid into L-phenylalanine in the presence of an amino group donor; or fumaric acid and ammonium ion or urea.
    Type: Grant
    Filed: February 1, 1985
    Date of Patent: November 8, 1988
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Kazumi Araki, Toshitsugu Ozeki, Yukiyoshi Ito, Shuichi Ishino, Hideharu Anazawa, Shigeru Kamimori
  • Patent number: 4495283
    Abstract: L-histidine is produced by culturing, in a nutrient medium, an L-histidine producing mutant microorganism belonging to the genus Corynebacterium or Brevibacterium. The mutant is resistant to growth inhibition by an RNA polymerase inhibitor or requires adenine. L-histidine is accumulated in the culture liquor and is recovered therefrom.
    Type: Grant
    Filed: April 7, 1983
    Date of Patent: January 22, 1985
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Kazumi Araki, Tetsuro Kuga
  • Patent number: 4183786
    Abstract: A process for converting glycine to L-serine is effected by the use of an aqueous medium containing glycine and microbial cells of a mutant belonging to the genus Nocardia. The mutant is capable of converting glycine to L-serine and has no or lowered ability to decompose L-serine and/or a resistance to at least one metabolic antagonist selected from those of glycine, serine, methionine, glutamine, histidine, leucine, isoleucine, valine, purine, pyrimidine or folic acid. The L-serine is accumulated in the aqueous medium and is recovered therefrom.
    Type: Grant
    Filed: November 28, 1977
    Date of Patent: January 15, 1980
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Kiyoshi Nakayama, Kazumi Araki, Yoshitake Tanaka
  • Patent number: 4169763
    Abstract: A process for producing L-lysine by fermentation includes the steps of culturing a strain belonging to the genus Corynebacterium having both an ability to produce L-lysine and a resistance to at least one member selected from the group consisting of aspartic acid analogs and sulfa drugs in a nutrient medium, forming and accumulating L-lysine in the resulting culture liquor and thereafter recovering the L-lysine therefrom.
    Type: Grant
    Filed: July 11, 1977
    Date of Patent: October 2, 1979
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Kiyoshi Nakayama, Kazumi Araki, Yoshitake Tanaka
  • Patent number: 4086137
    Abstract: L-arginine is produced by fermentation of a microorganism belonging to the genus Bacillus capable of producing L-arginine and having a nutritional requirement for at least one compound of the group consisting of methionine, histidine, threonine, proline, isoleucine, lysine, adenine, guanine and uracil or its precursor. L-arginine is accumulated in the culture liquor and may be recovered therefrom.
    Type: Grant
    Filed: February 8, 1977
    Date of Patent: April 25, 1978
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Kiyoshi Nakayama, Kazumi Araki, Hajime Yoshida